The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia
Clinical trial NCT05599880 · RECRUITING
Trial details
- NCT number
- NCT05599880
- Sponsor
- Seoul National University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-07
- Primary completion
- 2027-12-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.